Globe Life Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
7.2%projected annual EPS growth
Analyst Coverage
11analysts covering
FY Revenue (est.)
$6.4Bnext fiscal year
FY EPS (est.)
$15.71next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 26 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Net Operating Income per Diluted Share Quarterly343.0%Target: 15.40 to 15.90
Life Insurance Net Sales Growth Quarterly600.0%
Health Insurance Net Sales Growth Quarterly5,800.0%
Book Value per Share (excluding AOCI) Quarterly98.6
Watch Items
- Regulatory and Investigative Overhang
- Agent Salesforce Recruitment and Retention
- Underwriting Margin Compression in Supplemental Health
Research as of 2 Sep 2026